Lexaria Bioscience Corp (LEXX)
2.09
-0.07
(-3.24%)
USD |
NASDAQ |
Nov 22, 13:30
Lexaria Bioscience EPS Diluted (Quarterly): -0.13 for May 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2024 | -0.13 |
| February 29, 2024 | -0.06 |
| November 30, 2023 | -0.13 |
| August 31, 2023 | -0.12 |
| May 31, 2023 | -0.37 |
| February 28, 2023 | -0.22 |
| November 30, 2022 | -0.30 |
| August 31, 2022 | -0.24 |
| May 31, 2022 | -0.41 |
| February 28, 2022 | -0.25 |
| November 30, 2021 | -0.35 |
| August 31, 2021 | -0.24 |
| May 31, 2021 | -0.50 |
| February 28, 2021 | 0.09 |
| November 30, 2020 | -0.24 |
| August 31, 2020 | -0.24 |
| May 31, 2020 | -0.50 |
| February 29, 2020 | -0.38 |
| November 30, 2019 | -0.33 |
| August 31, 2019 | -0.30 |
| May 31, 2019 | -0.30 |
| February 28, 2019 | -0.30 |
| November 30, 2018 | -0.30 |
| August 31, 2018 | -0.30 |
| May 31, 2018 | -1.50 |
| Date | Value |
|---|---|
| February 28, 2018 | -0.60 |
| November 30, 2017 | -0.30 |
| August 31, 2017 | -0.30 |
| May 31, 2017 | -0.30 |
| February 28, 2017 | -0.30 |
| November 30, 2016 | -0.30 |
| August 31, 2016 | -0.30 |
| May 31, 2016 | -0.30 |
| February 29, 2016 | -0.30 |
| November 30, 2015 | -0.30 |
| August 31, 2015 | -0.1091 |
| May 31, 2015 | -0.2727 |
| February 28, 2015 | -0.2727 |
| November 30, 2014 | -0.2727 |
| July 31, 2014 | -0.5455 |
| April 30, 2014 | -0.5455 |
| January 31, 2014 | -0.2727 |
| October 31, 2013 | -0.2727 |
| July 31, 2013 | -0.0957 |
| April 30, 2013 | -0.0789 |
| January 31, 2013 | -0.2727 |
| October 31, 2012 | 0.00 |
| July 31, 2012 | 0.1131 |
| April 30, 2012 | -0.2727 |
| January 31, 2012 | -0.2727 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.50
Minimum
May 2020
0.09
Maximum
Feb 2021
-0.2589
Average
-0.24
Median
Aug 2020
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 0.10 |
| Edesa Biotech Inc | -0.52 |
| Xenon Pharmaceuticals Inc | -0.81 |
| ESSA Pharma Inc | -0.16 |
| ImmunoPrecise Antibodies Ltd | -0.1095 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.782M |
| Revenue (Quarterly) | 0.084M |
| Total Expenses (Quarterly) | 1.827M |
| Enterprise Value | 25.27M |
| Profit Margin (Quarterly) | -2.12K% |
| Earnings Yield | -21.05% |
| Normalized Earnings Yield | -19.85 |